Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 3—March 2024
Research

Monitoring and Characteristics of Mpox Contacts, Virginia, USA, May–November 2022

Eleanor N. FieldComments to Author , Elizabeth McCarty, Dawn Saady, and Brandy Darby
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E.N. Field); Virginia Department of Health, Richmond, Virginia, USA (E.N. Field, E. McCarty, D. Saady, B. Darby)

Main Article

Figure 2

Reported monkeypox virus exposure setting categories from mpox contact tracing and symptom monitoring cohort (n = 991), Virginia, USA, May 1–November 1, 2022. For persons in whom mpox developed while being monitored (n = 28), asterisk indicates where initial reported exposure setting differed from most likely infection source.

Figure 2. Reported monkeypox virus exposure setting categories from mpox contact tracing and symptom monitoring cohort (n = 991), Virginia, USA, May 1–November 1, 2022. For persons in whom mpox developed while being monitored (n = 28), asterisk indicates where initial reported exposure setting differed from most likely infection source.

Main Article

Page created: January 18, 2024
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external